Morgan Stanley
STJ

Morgan Stanley’s St Jude Medical STJ Stock Holding History

Morgan Stanley’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-6,705,713
Closed -$538M – 6746
2016
Q4 		$538M Buy
6,705,713
+2,130,085
+47% +$169M 0.18% 124
2016
Q3 		$365M Sell
4,575,628
-351,485
-7% -$28.4M 0.12% 175
2016
Q2 		$384M Buy
4,927,113
+4,003,600
+434% +$285M 0.14% 161
2016
Q1 		$50.8M Buy
923,513
+248,488
+37% +$13.5M 0.02% 744
2015
Q4 		$41.7M Sell
675,025
-354,177
-34% -$22.3M 0.02% 897
2015
Q3 		$64.9M Buy
1,029,202
+407,066
+65% +$29.1M 0.02% 653
2015
Q2 		$45.5M Sell
622,136
-325,178
-34% -$23.5M 0.02% 922
2015
Q1 		$62M Buy
947,314
+171,464
+22% +$11.4M 0.02% 724
2014
Q4 		$50.5M Sell
775,850
-385,591
-33% -$24.8M 0.02% 857
2014
Q3 		$69.8M Buy
1,161,441
+809,597
+230% +$52.9M 0.03% 666
2014
Q2 		$24.4M Sell
351,844
-432,485
-55% -$28M 0.01% 1261
2014
Q1 		$51.3M Buy
784,329
+556,265
+244% +$36.2M 0.02% 733
2013
Q4 		$14.1M Sell
228,064
-173,379
-43% -$10M 0.01% 1631
2013
Q3 		$21.5M Buy
401,443
+93,871
+31% +$4.83M 0.01% 1170
2013
Q2 		$14M Buy
+307,572
New +$13.3M 0.01% 1433

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Morgan Stanley's STJ Position: Q1 2017 in Review

Morgan Stanley sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 6,705,713 shares — an estimated $538M sold.

Morgan Stanley first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $538M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Morgan Stanley reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Morgan Stanley sold 6,705,713 St Jude Medical shares in Q1 2017, an estimated $538M.
  • Morgan Stanley first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Morgan Stanley's St Jude Medical position peaked at $538M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Morgan Stanley's 13F filing for Q1 2017, filed 12 May 2017.